We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+12.31%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$404M
AUM Growth
+$43.8M
Cap. Flow
+$3.63M
Cap. Flow %
0.9%
Top 10 Hldgs %
35.35%
Holding
158
New
9
Increased
66
Reduced
43
Closed
1

Top Buys

Rank Stock Value
1
XYL icon
Xylem
XYL
+$1.81M
2
STKL
SunOpta
STKL
+$1.75M
3
CLH icon
Clean Harbors
CLH
+$1.27M
4
CNI icon
Canadian National Railway
CNI
+$694K
5
TGT icon
Target
TGT
+$650K

Sector Composition

Rank Sector Weight
1 Healthcare 29.68%
2 Technology 24.09%
3 Industrials 17%
4 Consumer Staples 10.7%
5 Financials 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$339B
$21.4M 5.29%
262,596
+1,512
+0.6% +$123K
CVS icon
2
CVS Health
CVS
$122B
$19.6M 4.86%
274,176
+3,630
+1% +$233K
JCI icon
3
Johnson Controls International
JCI
$92.2B
$15.5M 3.84%
289,129
-935
-0.3% -$46K
ADP icon
4
Automatic Data Processing
ADP
$108B
$14.6M 3.62%
206,115
+183
+0.1% +$12.3K
EMR icon
5
Emerson Electric
EMR
$88.3B
$13.3M 3.29%
189,654
+2,815
+2% +$188K
JNJ icon
6
Johnson & Johnson
JNJ
$625B
$13.3M 3.28%
144,941
+1,665
+1% +$153K
NVS icon
7
Novartis
NVS
$297B
$13.2M 3.25%
182,619
+2,143
+1% +$149K
GSK icon
8
GSK
GSK
$106B
$12.5M 3.1%
187,706
+8,228
+5% +$534K
EMC
9
DELISTED
EMC CORPORATION
EMC
$9.94M 2.46%
395,082
+20,085
+5% +$487K
ILMN icon
10
Illumina
ILMN
$28.4B
$9.5M 2.35%
88,274
-52
-0.1% -$4.76K
ROK icon
11
Rockwell Automation
ROK
$49B
$9.34M 2.31%
79,034
+3,495
+5% +$388K
AAPL icon
12
Apple
AAPL
$4.57T
$9.31M 2.3%
464,660
+12,376
+3% +$234K
TEVA icon
13
Teva Pharmaceuticals
TEVA
$41.2B
$8.52M 2.11%
212,581
-22,485
-10% -$885K
SSYS icon
14
Stratasys
SSYS
$774M
$8.51M 2.11%
63,202
-2,530
-4% -$293K
CNI icon
15
Canadian National Railway
CNI
$76.6B
$7.95M 1.97%
139,430
+12,612
+10% +$694K
ATR icon
16
AptarGroup
ATR
$8.61B
$7.63M 1.89%
112,525
+1,228
+1% +$78.3K
MA icon
17
Mastercard
MA
$493B
$7.48M 1.85%
89,570
+270
+0.3% +$20.1K
CSCO icon
18
Cisco
CSCO
$479B
$7.13M 1.76%
318,023
+1,225
+0.4% +$27.1K
GLW icon
19
Corning
GLW
$143B
$7.09M 1.75%
397,770
+12,345
+3% +$203K
PRGO icon
20
Perrigo
PRGO
$1.78B
$7M 1.73%
45,634
-4,246
-9% -$612K
NXPI icon
21
NXP Semiconductors
NXPI
$60.4B
$6.59M 1.63%
143,443
-63,187
-31% -$2.6M
INTC icon
22
Intel
INTC
$513B
$6.5M 1.61%
250,568
+2,322
+0.9% +$56.2K
LH icon
23
Labcorp
LH
$25.9B
$6.38M 1.58%
81,262
+512
+0.6% +$43.7K
COV
24
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$5.83M 1.44%
85,616
+5,080
+6% +$331K
IPGP icon
25
IPG Photonics
IPGP
$3.84B
$5.65M 1.4%
72,791
+4,500
+7% +$306K

Similar funds

Reynders McVeigh Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Reynders McVeigh Capital Management held 158 positions worth $404M, up 12% from $360M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Reynders McVeigh Capital Management's Q4 2013 filing shows 9 new, 66 increased, 43 reduced and 1 closed positions. Its largest new stake was Vanguard Morningstar Growth ETF: 28,032 shares worth $435K. The largest sale was Teradata, an estimated $3.94M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q4 2013 buy was Vanguard Morningstar Growth ETF: 28,032 shares worth $435K.
  • Reynders McVeigh Capital Management added most to Xylem in Q4 2013, an estimated $1.81M increase.
  • Reynders McVeigh Capital Management's biggest Q4 2013 reduction was Teradata, cutting an estimated $3.94M.
  • Reynders McVeigh Capital Management fully exited Monsanto Co in Q4 2013, selling an estimated $482K.
  • Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $404M portfolio in Q4 2013.
  • Reynders McVeigh Capital Management opened 9 new positions and closed 1 in Q4 2013.
  • Reynders McVeigh Capital Management's portfolio value rose 12% quarter-over-quarter to $404M.

Based on Reynders McVeigh Capital Management's 13F filing for Q4 2013, filed 7 Feb 2014.